Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 2
2007 4
2009 2
2010 1
2014 1
2015 4
2016 2
2017 1
2018 4
2019 7
2020 5
2021 2
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Management of patients with extensive small-cell lung cancer in the immunotherapy era: an Italian consensus through a Delphi approach.
Ceresoli GL, Rossi G, Agustoni F, Bonomi L, Borghetti P, Bulotta A, Casartelli C, Cerea G, Colonese F, Del Signore E, Finocchiaro G, Gianoncelli L, Grisanti S, Maiolani M, Pagni F, Proto C, Rijavec E, Vittimberga I, Arcangeli S, Filippi AR. Ceresoli GL, et al. Among authors: finocchiaro g. Crit Rev Oncol Hematol. 2024 Jan 31:104247. doi: 10.1016/j.critrevonc.2023.104247. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 38307393 Review.
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round.
Antonicelli A, Muriana P, Favaro G, Mangiameli G, Lanza E, Profili M, Bianchi F, Fina E, Ferrante G, Ghislandi S, Pistillo D, Finocchiaro G, Condorelli G, Lembo R, Novellis P, Dieci E, De Santis S, Veronesi G. Antonicelli A, et al. Among authors: finocchiaro g. Cancers (Basel). 2024 Jan 18;16(2):417. doi: 10.3390/cancers16020417. Cancers (Basel). 2024. PMID: 38254906 Free PMC article.
The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?
Rossi S, Pagliaro A, Michelini A, Navarria P, Clerici E, Franceschini D, Toschi L, Finocchiaro G, Scorsetti M, Santoro A. Rossi S, et al. Among authors: finocchiaro g. Cancers (Basel). 2023 Dec 8;15(24):5761. doi: 10.3390/cancers15245761. Cancers (Basel). 2023. PMID: 38136306 Free PMC article. Review.
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results.
Gutierrez M, Lam WS, Hellmann MD, Gubens MA, Aggarwal C, Tan DSW, Felip E, Chiu JWY, Lee JS, Yang JC, Garon EB, Finocchiaro G, Ahn MJ, Luft A, Landers GA, Basso A, Ma H, Kobie J, Palcza J, Cristescu R, Fong L, Snyder A, Yuan J, Herbst RS. Gutierrez M, et al. Among authors: finocchiaro g. Nat Med. 2023 Jul;29(7):1718-1727. doi: 10.1038/s41591-023-02385-6. Epub 2023 Jul 10. Nat Med. 2023. PMID: 37429923 Clinical Trial.
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis.
Bestvina CM, Whisenant JG, Torri V, Cortellini A, Wakelee H, Peters S, Roca E, De Toma A, Hirsch FR, Mamdani H, Halmos B, Arrieta O, Metivier AC, Fidler MJ, Rogado J, Presley CJ, Mascaux C, Genova C, Blaquier JB, Addeo A, Finocchiaro G, Khan H, Mazieres J, Morgillo F, Bar J, Aujayeb A, Mountzios G, Scotti V, Grosso F, Geraedts E, Zhumagaliyeva AN, Horn L, Garassino MC, Baena J; TERAVOLT study group. Bestvina CM, et al. Among authors: finocchiaro g. JTO Clin Res Rep. 2022 Aug;3(8):100335. doi: 10.1016/j.jtocrr.2022.100335. Epub 2022 May 20. JTO Clin Res Rep. 2022. PMID: 35619644 Free PMC article.
Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer.
Fina E, Federico D, Novellis P, Dieci E, Monterisi S, Cioffi F, Mangiameli G, Finocchiaro G, Alloisio M, Veronesi G. Fina E, et al. Among authors: finocchiaro g. Cancers (Basel). 2021 Sep 6;13(17):4488. doi: 10.3390/cancers13174488. Cancers (Basel). 2021. PMID: 34503298 Free PMC article.
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
Luciani A, Marra A, Toschi L, Cortinovis D, Fava S, Filipazzi V, Tuzi A, Cerea G, Rossi S, Perfetti V, Rossi A, Giannetta L, Sala L, Finocchiaro G, Pizzutilo EG, Carelli S, Agustoni F, Cergnul M, Zonato S, Siena S, Bidoli P, Ferrari D. Luciani A, et al. Among authors: finocchiaro g. Clin Lung Cancer. 2020 Nov;21(6):e567-e571. doi: 10.1016/j.cllc.2020.05.004. Epub 2020 May 13. Clin Lung Cancer. 2020. PMID: 32591311
41 results